Published in Front Immunol on April 22, 2016
Infection-adapted emergency hematopoiesis promotes visceral leishmaniasis. PLoS Pathog (2017) 0.76
Lipid bodies accumulation in Leishmania infantum-infected C57BL/6 macrophages. Parasite Immunol (2017) 0.75
PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol (2008) 19.24
Leishmaniasis worldwide and global estimates of its incidence. PLoS One (2012) 18.07
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity (2007) 8.94
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol (2007) 7.36
The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg (2001) 6.02
CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol (2005) 4.11
Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur J Immunol (2004) 3.18
Clinical spectrum of Leishmaniasis. Clin Infect Dis (1996) 2.94
Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol (2011) 2.93
Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy. Proc Natl Acad Sci U S A (2007) 2.41
Leishmaniasis: an update of current pharmacotherapy. Expert Opin Pharmacother (2012) 2.03
IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J Immunol (2009) 2.00
Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas? Bull World Health Organ (1992) 1.95
Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect Immun (2002) 1.85
Management of trypanosomiasis and leishmaniasis. Br Med Bull (2012) 1.78
Leishmania donovani targets Dicer1 to downregulate miR-122, lower serum cholesterol, and facilitate murine liver infection. Cell Host Microbe (2013) 1.77
Tissue granuloma structure-function in experimental visceral leishmaniasis. Int J Exp Pathol (2001) 1.67
Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function. Immunity (2008) 1.65
The immunopathology of experimental visceral leishmaniasis. Immunol Rev (2004) 1.64
Balancing immunity and pathology in visceral leishmaniasis. Immunol Cell Biol (2006) 1.55
IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J Clin Invest (2009) 1.53
Inflammasome-derived IL-1β production induces nitric oxide-mediated resistance to Leishmania. Nat Med (2013) 1.46
IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. J Immunol (2011) 1.44
Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat Immunol (2002) 1.44
Hepatic stellate cells regulate liver immunity to visceral leishmaniasis through P110δ-dependent induction and expansion of regulatory T cells in mice. Hepatology (2015) 1.44
Invasion and intracellular survival by protozoan parasites. Immunol Rev (2011) 1.43
RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages. Eur J Immunol (2006) 1.41
Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani. Infect Immun (2007) 1.36
Destruction of follicular dendritic cells during chronic visceral leishmaniasis. J Immunol (1997) 1.36
Drug resistance in visceral leishmaniasis. J Biomed Biotechnol (2009) 1.35
IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. J Infect Dis (2011) 1.33
The spleen in local and systemic regulation of immunity. Immunity (2013) 1.33
Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells. PLoS Pathog (2010) 1.32
B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections. PLoS Pathog (2009) 1.27
Immunoactivation and immunopathogeny during active visceral leishmaniasis. Rev Inst Med Trop Sao Paulo (2009) 1.19
Programmed death 1-mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function. J Immunol (2013) 1.14
Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis. PLoS Pathog (2008) 1.11
The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response. Front Cell Infect Microbiol (2012) 1.08
Hematologic changes in visceral leishmaniasis/kala azar. Indian J Hematol Blood Transfus (2010) 1.07
Cytokines in the differentiation of Th1/Th2 CD4+ subsets in leishmaniasis. J Cell Biochem (1993) 1.03
Toll-like receptors in leishmania infections: guardians or promoters? J Parasitol Res (2012) 1.03
Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection. Exp Parasitol (2001) 1.01
Regulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasis. PLoS One (2012) 1.00
IL-10-producing Th1 cells and disease progression are regulated by distinct CD11c⁺ cell populations during visceral leishmaniasis. PLoS Pathog (2012) 1.00
Organ-specific immunity in canine visceral leishmaniasis: analysis of symptomatic and asymptomatic dogs naturally infected with Leishmania chagasi. Am J Trop Med Hyg (2004) 0.98
Liver morphology and function in visceral leishmaniasis (Kala-azar). J Clin Pathol (1994) 0.97
Enhanced hematopoietic activity accompanies parasite expansion in the spleen and bone marrow of mice infected with Leishmania donovani. Infect Immun (2000) 0.97
Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection. PLoS Pathog (2011) 0.96
Computer aided selection of candidate vaccine antigens. Immunome Res (2010) 0.95
Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines. J Infect Dis (2012) 0.95
Leishmania donovani infection of bone marrow stromal macrophages selectively enhances myelopoiesis, by a mechanism involving GM-CSF and TNF-alpha. Blood (2000) 0.95
CD40 expression levels modulate regulatory T cells in Leishmania donovani infection. J Immunol (2010) 0.94
Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice. J Clin Invest (2010) 0.92
Compartment-specific remodeling of splenic micro-architecture during experimental visceral leishmaniasis. Am J Pathol (2011) 0.92
Human visceral leishmaniasis: decrease in serum cholesterol as a function of splenic parasite load. Ann Trop Med Parasitol (2011) 0.92
Inflammation and structural changes of splenic lymphoid tissue in visceral leishmaniasis: a study on naturally infected dogs. Parasite Immunol (2007) 0.89
IL-1β (-511T/C) gene polymorphism not IL-1β (+3953T/C) and LT-α (+252A/G) gene variants confers susceptibility to visceral leishmaniasis. Mol Biol Rep (2012) 0.89
Role of CD8(+) T cells in protection against Leishmania donovani infection in healed Visceral Leishmaniasis individuals. BMC Infect Dis (2014) 0.88
Identification of TLR inducing Th1-responsive Leishmania donovani amastigote-specific antigens. Mol Cell Biochem (2011) 0.88
Immune regulation during chronic visceral leishmaniasis. PLoS Negl Trop Dis (2014) 0.88
Clinico-hematological characteristics in patients with kala azar. A study from north-west India. Trop Geogr Med (1991) 0.88
A transcriptomic network identified in uninfected macrophages responding to inflammation controls intracellular pathogen survival. Cell Host Microbe (2013) 0.86
Leishmania donovani-induced expression of signal regulatory protein alpha on Kupffer cells enhances hepatic invariant NKT-cell activation. Eur J Immunol (2010) 0.86
Antigen-Pulsed CpG-ODN-Activated Dendritic Cells Induce Host-Protective Immune Response by Regulating the T Regulatory Cell Functioning in Leishmania donovani-Infected Mice: Critical Role of CXCL10. Front Immunol (2014) 0.85
Immunomodulators: use in combined therapy against leishmaniasis. Expert Rev Anti Infect Ther (2010) 0.85
Hepatic extracellular matrix alterations in dogs naturally infected with Leishmania (Leishmania) chagasi. Int J Exp Pathol (2009) 0.85
Cytokines and visceral leishmaniasis: a comparison of plasma cytokine profiles between the clinical forms of visceral leishmaniasis. Mem Inst Oswaldo Cruz (2012) 0.85
Involvement of CD4⁺ Foxp3⁺ regulatory T cells in persistence of Leishmania donovani in the liver of alymphoplastic aly/aly mice. PLoS Negl Trop Dis (2012) 0.82
Lactate dehydrogenase and other enzymes in kala-azar patients in Iraq. Indian J Med Res (1979) 0.82
Interferon regulatory factor 7 contributes to the control of Leishmania donovani in the mouse liver. Infect Immun (2010) 0.82
A Petri net model of granulomatous inflammation: implications for IL-10 mediated control of Leishmania donovani infection. PLoS Comput Biol (2013) 0.82
Leishmania donovani infection induces anemia in hamsters by differentially altering erythropoiesis in bone marrow and spleen. PLoS One (2013) 0.81
Splenectomy in a patient with treatment-resistant visceral leishmaniasis: a case report. Rev Soc Bras Med Trop (2012) 0.81
Parasite load induces progressive spleen architecture breakage and impairs cytokine mRNA expression in Leishmania infantum-naturally infected dogs. PLoS One (2015) 0.81
The endogenous origin of blood cholesterol. J Biol Chem (1957) 0.80
Protective role of 5-lipoxigenase during Leishmania infantum infection is associated with Th17 subset. Biomed Res Int (2014) 0.80
The neurotrophic receptor Ntrk2 directs lymphoid tissue neovascularization during Leishmania donovani infection. PLoS Pathog (2015) 0.78
IL-17A-Producing γδ T Cells Suppress Early Control of Parasite Growth by Monocytes in the Liver. J Immunol (2015) 0.77
Leishmania donovani amastigote components-induced colony-stimulating factors production. Parasitol Int (2005) 0.77
Lipoprotein lipase and PPAR alpha gene polymorphisms, increased very-low-density lipoprotein levels, and decreased high-density lipoprotein levels as risk markers for the development of visceral leishmaniasis by Leishmania infantum. Mediators Inflamm (2014) 0.77
Novel markers of inflammatory response and hepatic dysfunction in canine leishmaniasis. Comp Immunol Microbiol Infect Dis (2015) 0.76
The use of systems biology and immunological big data to guide vaccine development. Genome Med (2015) 0.76
[Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection]. An Med Interna (2000) 0.76
A case of conventional treatment failure in visceral leishmaniasis: leukocyte distribution and cytokine expression in splenic compartments. BMC Infect Dis (2014) 0.76
[Visceral leishmaniasis presenting with peripheral leukocytosis and lymphocytosis]. Sangre (Barc) (1994) 0.76
High levels of CD4⁺ CTLA-4⁺ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis. Eur J Clin Microbiol Infect Dis (2014) 0.76